Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel DiseaseTang, Yida; Qiao, Shubin; Su, Xi; Chen, Yundai; Jin, Zening; Chen, Hui; Xu, Biao; Kong, Xiangqing; Pang, Wenyue; Liu, Yong; Yu, Zaixin; Li, Xue; Li, Hui; Zhao, Yanyan; Wang, Yang; Li, Wei; Tian, Jian; Guan, Changdong; Xu, Bo; Gao, Runlin; Gao, Runlin; Qiao, Shubin; Gao, Runlin; Xu, Bo; Tang, Yida; Qiao, Shubin; Su, Xi; Zeng, Yong; Yang, Qing; Zhang, Jian; Gao, Runlin; Qiao, Shubin; Xu, Bo; Tang, Yida; Guan, Changdong; Tian, Jian; Chen, Jue; Wu, Yongjian; Yan, Hongbin; Yang, Yuejin; Su, Xi; Wang, Min; Wang, Jiangyou; Xu, Wenjie; Chen, Yundai; Jin, Qinhua; Jin, Zening; Yang, Duo; Meng, Shuai; Chen, Hui; Liang, Siwen; Yao, Daokuo; Li, Dongbao; Xu, Biao; Song, Jie; Dai, Qing; Wang, Kun; Kang, Lina; Wang, Lian; Kong, Xiangqing; Wang, Hui; Wang, Liansheng; Pang, Wenyue; Wan, Jiye; Liu, Yong; Wei, Liudong; He, Feng; Xing, Xiaochun; Yu, Zaixin; Wang, Duanzheng; Jin, Ran; Li, Xue; Xue, Yusheng; Wang, Bin; Li, Hui; Wang, Manqing; Wang, Jijia · JACC: Cardiovascular Interventions · 2018

The Status and Characteristics of Urinary Stone Composition in ChinaYe, Zhangqun; Zeng, Guohua; Huan, Yang; Li, Jianxin; Tang, Kun; Wang, Guomin; Wang, Shusheng; Yu, Yonggang; Wang, Yujie; Zhang, Tao; Long, Yongfu; Li, Weibin; Wang, Changmin; Wang, Wei; Gao, Sihe; Shan, Yuxi; Huang, Xiaobo; Bai, Zhiming; Lin, Xiaohan; Cheng, Yue; Wang, Qinzhang; Xu, Zhuoqun; Xie, Liping; Yuan, Jianlin; Ren, Shengqiang; Fan, Yuhui; Pan, Tiejun; Wang, Jing; Li, Xun; Chen, Xuehua; Gu, Xiaojian; Sun, Zhaolin; Xiao, Kefeng; Jia, Jianye; Zhang, Qinghua; Wang, Gongxian; Sun, Ting; Li, Xuedong; Xu, Changbao; Xu, Chuangliang; Shi, Guowei; He, Jiayang; Song, Leming; Sun, Guang; Wang, Dongwen; Liu, Yili; Wang, Chunxi; Han, Yi; Liang, Peiyu; Wang, Zhiping; He, Wei; Chen, Zhiqiang; Xing, Jinchun; Xu, Hua · BJU International · 2019

Interfacial Nanoinjection‐Based Nanoliter Single‐Cell AnalysisYun, Juanli; Zheng, Xiaowei; Xu, Peng; Zheng, Xu; Xu, Jingyue; Cao, Chen; Fu, Yusi; Xu, Bingxue; Dai, Xin; Wang, Yi; Liu, Hongtao; Yi, Qiaolian; Zhu, Yaxin; Wang, Jian; Wang, Li; Dong, Zhiyang; Huang, Li; Huang, Yanyi; Du, Wenbin · Small · 2019

Prevalence of mental disorders in China: a cross-sectional epidemiological studyHuang, Yueqin; Wang, Yu; Wang, Hong; Liu, Zhaorui; Yu, Xin; Yan, Jie; Yu, Yaqin; Kou, Changgui; Xu, Xiufeng; Lu, Jin; Wang, Zhizhong; He, Shulan; Xu, Yifeng; He, Yanling; Li, Tao; Guo, Wanjun; Tian, Hongjun; Xu, Guangming; Xu, Xiangdong; Ma, Yanjuan; Wang, Linhong; Wang, Limin; Yan, Yongping; Wang, Bo; Xiao, Shuiyuan; Zhou, Liang; Li, Lingjiang; Tan, Liwen; Zhang, Tingting; Ma, Chao; Li, Qiang; Ding, Hua; Geng, Hongchun; Jia, Fujun; Shi, Jianfei; Wang, Shiliang; Zhang, Ning; Du, Xinbai; Du, Xiangdong; Wu, Yue · The Lancet Psychiatry · 2019

The China Mental Health Survey: II. Design and field proceduresLiu, Zhaorui; Huang, Yueqin; Lv, Ping; Zhang, Tingting; Wang, Hong; Li, Qiang; Yan, Jie; Yu, Yaqin; Kou, Changgui; Xu, Xiufeng; Lu, Jin; Wang, Zhizhong; Qiu, Hongyan; Xu, Yifeng; He, Yanling; Li, Tao; Guo, Wanjun; Tian, Hongjun; Xu, Guangming; Xu, Xiangdong; Ma, Yanjuan; Wang, Linhong; Wang, Limin; Yan, Yongping; Wang, Bo; Xiao, Shuiyuan; Zhou, Liang; Li, Lingjiang; Tan, Liwen; Chen, Hongguang; Ma, Chao · Social Psychiatry and Psychiatric Epidemiology · 2016

The China Mental Health Survey (CMHS): I. background, aims and measuresHuang, Yueqin; Liu, Zhaorui; Wang, Hong; Guan, Xing; Chen, Hongguang; Ma, Chao; Li, Qiang; Yan, Jie; Yu, Yaqin; Kou, Changgui; Xu, Xiufeng; Lu, Jin; Wang, Zhizhong; Liu, Lan; Xu, Yifeng; He, Yanling; Li, Tao; Guo, Wanjun; Tian, Hongjun; Xu, Guangming; Xu, Xiangdong; Lv, Shuyun; Wang, Linhong; Wang, Limin; Yan, Yongping; Wang, Bo; Xiao, Shuiyuan; Zhou, Liang; Li, Lingjiang; Tan, Liwen · Social Psychiatry and Psychiatric Epidemiology · 2016

Efficient multi-wavelength lasers made of Nd:GdLuAG crystalYongguang Zhao, Yongguang Zhao; Zhengping Wang, Zhengping Wang; Haohai Yu, Haohai Yu; Xiaodong Xu, Xiaodong Xu; Jun Xu, Jun Xu; Xinguang Xu, Xinguang Xu · Chinese Optics Letters · 2015

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR -mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 studyZhong, Wen-Zhao; Wang, Qun; Mao, Wei-Min; Xu, Song-Tao; Wu, Lin; Shen, Yi; Liu, Yong-Yu; Chen, Chun; Cheng, Ying; Xu, Lin; Wang, Jun; Fei, Ke; Li, Xiao-Fei; Li, Jian; Huang, Cheng; Liu, Zhi-Dong; Xu, Shun; Chen, Ke-Neng; Xu, Shi-Dong; Liu, Lun-Xu; Yu, Ping; Wang, Bu-Hai; Ma, Hai-Tao; Yan, Hong-Hong; Yang, Xue-Ning; Zhou, Qing; Wu, Yi-Long; Wu, Yi-Long; Wang, Qun; Mao, Wei-Min; Wu, Lin; Shen, Yi; Liu, Yong-Yu; Chen, Chun; Cheng, Ying; Xu, Lin; Wang, Jun; Fei, Ke; Li, Xiao-Fei; Li, Jian; Huang, Cheng; Liu, Zhi-Dong; Xu, Shun; Chen, Ke-Neng; Xu, Shi-Dong; Liu, Lun-Xu; Yu, Ping; Wang, Bu-Hai; Ma, Hai-Tao; Wang, Si-Yu; Hu, Jian; Liu, Wei; Li, Wei; Shi, Jian-Hua · The Lancet Oncology · 2017